MiNK Therapeutics, Inc. (INKT) stock
INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$9.35+0.01 (+0.11%)
Close on Nov 16, 2026Market cap $47.71MP/E –Yield –
MiNK Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for MiNK Therapeutics
MiNK Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?